๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Increase of sulfated ursodeoxycholic acid in the serum and urine of patients with chronic liver disease after ursodeoxycholic acid therapy

โœ Scribed by KIMIHIDE NAKAMURA; MASASHI YONEDA; ATSUSHI KIMURA; KEISUKE TAMORI; SHIRO YOKOHAMA; YOICHI SATO; TAKAFUMI KATO; TAKENAO HASEGAWA; HIDEAKI SAITO; MASARU AOSHIMA; MASANORI FUJITA; ISAO MAKINO


Book ID
115170973
Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
549 KB
Volume
11
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Effects of ursodeoxycholic acid (UDCA) o
โœ E. Rolandi; R. Franceschini; A. Cataldi; V. Cicchetti; L. Carati; T. Barreca ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Springer ๐ŸŒ English โš– 347 KB

The effects of ursodeoxycholic acid (UDCA, 450 mg daily) in patients with histologically proven chronic active hepatitis (CAH) have been evaluated in a randomized, double-blind, placebo-controlled study. Twenty-six patients with serum alanine aminotransferase (ALT) values at least twice the normal u